MedPath

VEST Device to Enhance Safein Vein Patency

Completed
Conditions
Coronary Artery Bypass
Registration Number
NCT06500897
Lead Sponsor
Cardiochirurgia E.H.
Brief Summary

Purpose - Bypass grafting is the gold standard for severe coronary disease, yet most repeat revascularizations target previously grafted territories. External stenting of saphenous vein grafts, the most frequently used bypass conduit, has been shown to minimize disease markers. This study evaluates clinical outcomes of external stenting in real world routine practice.

Methods - Three centers enrolled a prospective real-world cohort of external- stenting- enhanced CABG patients. All patients received an internal mammary artery graft to the left anterior descending artery and additional arterial and/or venous grafts. One or more venous grafts were externally stented. Choice of conduits, use of cardiopulmonary bypass, and vein harvesting technique were performed according to the routine practice of each surgeon.

All patients were prescribed standard of care medication and were followed via on site visits or phone interviews for major adverse myocardial and cerebral effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
385
Inclusion Criteria
  • CABG with at least one VEST implant
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Re-rivascularizationUp to 7 years

Number of PCI or re-CABG performed, stratified by target site

MACCEUp to 7 years

Major adverse cardiac and cerebrovascular events

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Medical University of Vienna

🇦🇹

Vienna, Austria

Cardiochirurgia European Hospital

🇮🇹

Rome, Italy

Mauriziano Hospital

🇮🇹

Turin, Italy

Medical University of Vienna
🇦🇹Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath